# FDA 483 - Jaglowski, Samantha - February 14, 2018

Source: https://www.globalkeysolutions.net/records/483/jaglowski-samantha/01110719-9718-40dc-b528-dd604aa0d560

> FDA 483 for Jaglowski, Samantha on February 14, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Jaglowski, Samantha
- Inspection Date: 2018-02-14
- Product Type: drugs
- Office Name: Cincinnati District Office
- Summary: The FDA inspected Sterling Loving Hall in Columbus, OH, a clinical investigator. The inspection revealed that the firm failed to conduct an investigation in accordance with its investigational plan. Specifically, protocol-specified procedures for vital signs and chemistry panel laboratory evaluations were not performed for multiple subjects.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/geoffrey-k-kilili/b00aeedf-95bd-4ccf-a23e-6e12e60249c4)

Company: https://www.globalkeysolutions.net/companies/jaglowski-samantha/f00dcb0b-98e4-4f11-8aa6-35c0f833a57b

Office: https://www.globalkeysolutions.net/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22